Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use sterile implants and instrumentation for spinal surgery in France. It provides SteriSpine PS, for posture vixation; SteriSpine VA, a vertebral fracture solution; and SteriSpine CC/LC, an interbody fusion solution, including Walnut, Cedar, and Elm interbody cages. The company was founded in 2010 and is headquartered in Fleurieux-sur-l'Arbresle, France.
Research context
Safe Orthopaedics SA appears in PyInvesting’s Paris Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Safe Orthopaedics SA is currently in a long term downtrend where the price is trading 13.1% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
Based on the above factors, Safe Orthopaedics SA gets an overall score of 1/5.